{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T16:36:37Z","timestamp":1780418197361,"version":"3.54.1"},"reference-count":59,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100010311","name":"Guts UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010311","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011310","name":"Rural and Environment Science and Analytical Services Division","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011310","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicalnutritionjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Nutrition"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.clnu.2021.05.033","type":"journal-article","created":{"date-parts":[[2021,6,23]],"date-time":"2021-06-23T06:28:31Z","timestamp":1624429711000},"page":"5009-5019","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Prebiotic fructans have greater impact on luminal microbiology and CD3+ T cells in healthy siblings than patients with Crohn's disease: A pilot study investigating the potential for primary prevention of inflammatory bowel disease"],"prefix":"10.1016","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4921-8516","authenticated-orcid":false,"given":"Charlotte R.","family":"Hedin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4330-4747","authenticated-orcid":false,"given":"Neil E.","family":"McCarthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2115-2399","authenticated-orcid":false,"given":"Petra","family":"Louis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Freda M.","family":"Farquharson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2438-6086","authenticated-orcid":false,"given":"Sara","family":"McCartney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6588-0844","authenticated-orcid":false,"given":"Andrew J.","family":"Stagg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3353-9590","authenticated-orcid":false,"given":"James O.","family":"Lindsay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5414-2950","authenticated-orcid":false,"given":"Kevin","family":"Whelan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clnu.2021.05.033_bib1","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1093\/oxfordjournals.epirev.a036296","article-title":"Epidemiology of inflammatory bowel disease","volume":"8","author":"Calkins","year":"1986","journal-title":"Epidemiol Rev"},{"key":"10.1016\/j.clnu.2021.05.033_bib2","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/ajg.2015.50","article-title":"Familial risk of inflammatory bowel disease: a population-based cohort study 1977\u20132011","volume":"110","author":"Moller","year":"2015","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.clnu.2021.05.033_bib3","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1136\/gutjnl-2014-308896","article-title":"Siblings of patients with Crohn\u2019s disease exhibit a biologically relevant dysbiosis in mucosal microbial metacommunities","volume":"65","author":"Hedin","year":"2016","journal-title":"Gut"},{"key":"10.1016\/j.clnu.2021.05.033_bib4","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1136\/gutjnl-2013-306226","article-title":"Altered intestinal microbiota and blood T cell phenotype are shared by patients with Crohn\u2019s disease and their unaffected siblings","volume":"63","author":"Hedin","year":"2014","journal-title":"Gut"},{"key":"10.1016\/j.clnu.2021.05.033_bib5","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1136\/gut.2010.223263","article-title":"Dysbiosis of the faecal microbiota in patients with Crohn\u2019s disease and their unaffected relatives","volume":"60","author":"Joossens","year":"2011","journal-title":"Gut"},{"key":"10.1016\/j.clnu.2021.05.033_bib6","first-page":"1049","article-title":"Tissue studies in screened first-degree relatives reveal a distinct Crohn\u2019s disease phenotype","volume":"20","author":"Sorrentino","year":"2014","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.clnu.2021.05.033_bib7","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1016\/S0016-5085(03)00383-4","article-title":"Subclinical intestinal inflammation: an inherited abnormality in Crohn\u2019s disease relatives?","volume":"124","author":"Thjodleifsson","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clnu.2021.05.033_bib8","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1097\/MIB.0b013e318281f2d3","article-title":"Subclinical inflammation with increased neutrophil activity in healthy twin siblings reflect environmental influence in the pathogenesis of inflammatory bowel disease","volume":"19","author":"Zhulina","year":"2013","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.clnu.2021.05.033_bib9","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1136\/gut.2005.065557","article-title":"Genetic basis for increased intestinal permeability in families with Crohn\u2019s disease: role of CARD15 3020insC mutation?","volume":"55","author":"Buhner","year":"2006","journal-title":"Gut"},{"key":"10.1016\/j.clnu.2021.05.033_bib10","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1093\/ibd\/izz116","article-title":"Analysis of genetic association of intestinal permeability in healthy first-degree relatives of patients with Crohn\u2019s disease","volume":"25","author":"Turpin","year":"2019","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.clnu.2021.05.033_bib11","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.dld.2013.01.017","article-title":"Increased antibody response to microbial antigens in patients with Crohn\u2019s disease and their unaffected first-degree relatives","volume":"45","author":"Michielan","year":"2013","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.clnu.2021.05.033_bib12","doi-asserted-by":"crossref","first-page":"S-413","DOI":"10.1016\/S0016-5085(19)37883-7","article-title":"Elevated fecal calprotectin in healthy first degree relatives of patients with Crohn\u2019s disease is associated with future diagnosis of Crohn\u2019s disease","volume":"156","author":"Lee","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clnu.2021.05.033_bib13","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/nrgastro.2017.75","article-title":"Expert consensus document: the International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics","volume":"14","author":"Gibson","year":"2017","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.clnu.2021.05.033_bib14","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1097\/01.mpg.0000226376.95623.9f","article-title":"Nutritional approach to restore impaired intestinal barrier function and growth after neonatal stress in rats","volume":"43","author":"Garcia-Rodenas","year":"2006","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.clnu.2021.05.033_bib15","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.jnutbio.2014.10.011","article-title":"A potential role for regulatory T-cells in the amelioration of DSS induced colitis by dietary non-digestible polysaccharides","volume":"26","author":"Hartog","year":"2015","journal-title":"J Nutr Biochem"},{"key":"10.1016\/j.clnu.2021.05.033_bib16","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s00394-015-1068-x","article-title":"Preventive rather than therapeutic treatment with high fiber diet attenuates clinical and inflammatory markers of acute and chronic DSS-induced colitis in mice","volume":"56","author":"Silveira","year":"2017","journal-title":"Eur J Nutr"},{"key":"10.1016\/j.clnu.2021.05.033_bib17","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1080\/19490976.2018.1526583","article-title":"Inulin-type fructans improve active ulcerative colitis associated with microbiota changes and increased short-chain fatty acids levels","volume":"10","author":"Valcheva","year":"2019","journal-title":"Gut Microb"},{"key":"10.1016\/j.clnu.2021.05.033_bib18","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1136\/gutjnl-2011-300413","article-title":"Effect of oligofructose-enriched inulin (OF-IN) on bacterial composition and disease activity of patients with Crohn\u2019s disease: results from a double-blinded randomised controlled trial","volume":"61","author":"Joossens","year":"2012","journal-title":"Gut"},{"key":"10.1016\/j.clnu.2021.05.033_bib19","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.1007\/s10620-007-0171-0","article-title":"A meta-analysis on the efficacy of probiotics for maintenance of remission and prevention of clinical and endoscopic relapse in Crohn\u2019s disease","volume":"53","author":"Rahimi","year":"2008","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.clnu.2021.05.033_bib20","first-page":"CD006634","article-title":"Probiotics for induction of remission in Crohn\u2019s disease","author":"Butterworth","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.clnu.2021.05.033_bib21","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1136\/gut.2010.232025","article-title":"Randomised, double-blind, placebo-controlled trial of fructo-oligosaccharides in active Crohn\u2019s disease","volume":"60","author":"Benjamin","year":"2011","journal-title":"Gut"},{"key":"10.1016\/j.clnu.2021.05.033_bib22","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/0016-5085(95)90192-2","article-title":"Selective stimulation of bifidobacteria in the human colon by oligofructose and inulin","volume":"108","author":"Gibson","year":"1995","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clnu.2021.05.033_bib23","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1475-2891-5-8","article-title":"The capacity of short-chain fructo-oligosaccharides to stimulate faecal bifidobacteria: a dose-response relationship study in healthy humans","volume":"5","author":"Bouhnik","year":"2006","journal-title":"Nutr J"},{"key":"10.1016\/j.clnu.2021.05.033_bib24","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/ejcn.2010.272","article-title":"Validation of a food frequency questionnaire to measure intakes of inulin and oligofructose","volume":"65","author":"Dunn","year":"2011","journal-title":"Eur J Clin Nutr"},{"key":"10.1016\/j.clnu.2021.05.033_bib25","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1017\/S0007114508019880","article-title":"Effect of inulin on the human gut microbiota: stimulation of Bifidobacterium adolescentis and Faecalibacterium prausnitzii","volume":"101","author":"Ramirez-Farias","year":"2009","journal-title":"Br J Nutr"},{"key":"10.1016\/j.clnu.2021.05.033_bib26","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1136\/gut.2006.099929","article-title":"Zinc carnosine, a health food supplement that stabilises small bowel integrity and stimulates gut repair processes","volume":"56","author":"Mahmood","year":"2007","journal-title":"Gut"},{"key":"10.1016\/j.clnu.2021.05.033_bib27","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/0003-2697(87)90021-2","article-title":"Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction","volume":"162","author":"Chomczynski","year":"1987","journal-title":"Anal Biochem"},{"key":"10.1016\/j.clnu.2021.05.033_bib28","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/ar3204","article-title":"Promise and pitfalls of the immunochip","volume":"13","author":"Cortes","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.clnu.2021.05.033_bib29","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1038\/ng.717","article-title":"Genome-wide meta-analysis increases to 71 the number of confirmed Crohn\u2019s disease susceptibility loci","volume":"42","author":"Franke","year":"2010","journal-title":"Nat Genet"},{"key":"10.1016\/j.clnu.2021.05.033_bib30","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/ejhg.2012.107","article-title":"REGENT: a risk assessment and classification algorithm for genetic and environmental factors","volume":"21","author":"Crouch","year":"2013","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.clnu.2021.05.033_bib31","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1002\/gepi.20519","article-title":"Risk categorization for complex disorders according to genotype relative risk and precision in parameter estimates","volume":"34","author":"Goddard","year":"2010","journal-title":"Genet Epidemiol"},{"key":"10.1016\/j.clnu.2021.05.033_bib32","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.jada.2010.03.025","article-title":"Gastrointestinal tolerance of chicory inulin products","volume":"110","author":"Bonnema","year":"2010","journal-title":"J Am Diet Assoc"},{"key":"10.1016\/j.clnu.2021.05.033_bib33","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1136\/gutjnl-2011-300219","article-title":"The Manitoba Inflammatory Bowel Disease Cohort Study: a prospective longitudinal evaluation of the use of complementary and alternative medicine services and products","volume":"61","author":"Rawsthorne","year":"2012","journal-title":"Gut"},{"key":"10.1016\/j.clnu.2021.05.033_bib34","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1093\/ecco-jcc\/jjx073","article-title":"Fermentable carbohydrates [FODMAPs] exacerbate functional gastrointestinal symptoms in patients with inflammatory bowel disease: a randomised, double-blind, placebo-controlled, cross-over, Re-challenge trial","volume":"11","author":"Cox","year":"2017","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.clnu.2021.05.033_bib35","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1093\/ajcn\/nqy041","article-title":"Dietary fiber intervention on gut microbiota composition in healthy adults: a systematic review and meta-analysis","volume":"107","author":"So","year":"2018","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.clnu.2021.05.033_bib36","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1023\/A:1026664105112","article-title":"Inflammation does not decrease intraluminal pH in chronic inflammatory bowel disease","volume":"44","author":"Ewe","year":"1999","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.clnu.2021.05.033_bib37","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1023\/A:1018893409596","article-title":"Small intestinal transit time and intraluminal pH in ileocecal resected patients with Crohn\u2019s disease","volume":"43","author":"Fallingborg","year":"1998","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.clnu.2021.05.033_bib38","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1046\/j.1365-2036.1998.00358.x","article-title":"Gastrointestinal pH profiles in patients with inflammatory bowel disease","volume":"12","author":"Press","year":"1998","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.clnu.2021.05.033_bib39","first-page":"114","article-title":"Improved localizing method of radiopill in measurement of entire gastrointestinal pH profiles: colonic luminal pH in normal subjects and patients with Crohn\u2019s disease","volume":"92","author":"Sasaki","year":"1997","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.clnu.2021.05.033_bib40","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/j.1462-2920.2009.02066.x","article-title":"Diversity of human colonic butyrate-producing bacteria revealed by analysis of the butyryl-CoA:acetate CoA-transferase gene","volume":"12","author":"Louis","year":"2010","journal-title":"Environ Microbiol"},{"key":"10.1016\/j.clnu.2021.05.033_bib41","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/1574-6941.12186","article-title":"Prebiotic stimulation of human colonic butyrate-producing bacteria and bifidobacteria, in vitro","volume":"87","author":"Scott","year":"2014","journal-title":"FEMS Microbiol Ecol"},{"key":"10.1016\/j.clnu.2021.05.033_bib42","doi-asserted-by":"crossref","first-page":"6526","DOI":"10.1128\/AEM.00508-07","article-title":"Impact of pH on lactate formation and utilization by human fecal microbial communities","volume":"73","author":"Belenguer","year":"2007","journal-title":"Appl Environ Microbiol"},{"key":"10.1016\/j.clnu.2021.05.033_bib43","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1002\/ibd.21590","article-title":"Relationship between human intestinal dendritic cells, gut microbiota, and disease activity in Crohn\u2019s disease","volume":"17","author":"Ng","year":"2011","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.clnu.2021.05.033_bib44","first-page":"1007","article-title":"Roseburia intestinalis supernatant ameliorates colitis induced in mice by regulating the immune response","volume":"20","author":"Luo","year":"2019","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.clnu.2021.05.033_bib45","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.chom.2017.04.010","article-title":"Gut microbiome function predicts response to anti-integrin biologic therapy in inflammatory bowel diseases","volume":"21","author":"Ananthakrishnan","year":"2017","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.clnu.2021.05.033_bib46","doi-asserted-by":"crossref","first-page":"16731","DOI":"10.1073\/pnas.0804812105","article-title":"Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients","volume":"105","author":"Sokol","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.clnu.2021.05.033_bib47","first-page":"978","article-title":"Alterations in the intestinal microbiome (dysbiosis) as a predictor of relapse after infliximab withdrawal in crohn\u2019s disease","volume":"20","author":"Rajca","year":"2014","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.clnu.2021.05.033_bib48","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.cell.2014.08.006","article-title":"Immunoglobulin A coating identifies colitogenic bacteria in inflammatory bowel disease","volume":"158","author":"Palm","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.clnu.2021.05.033_bib49","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1093\/jn\/136.1.70","article-title":"Dietary fructooligosaccharides affect intestinal barrier function in healthy men","volume":"136","author":"Ten Bruggencate","year":"2006","journal-title":"J Nutr"},{"key":"10.1016\/j.clnu.2021.05.033_bib50","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.clnu.2003.12.002","volume":"23","author":"Jain","year":"2004","journal-title":"Clin Nutr"},{"key":"10.1016\/j.clnu.2021.05.033_bib51","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1136\/gut.2003.024620","article-title":"Randomised clinical trial of synbiotic therapy in elective surgical patients","volume":"53","author":"Anderson","year":"2004","journal-title":"Gut"},{"key":"10.1016\/j.clnu.2021.05.033_bib52","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.burns.2004.11.017","article-title":"Prebiotic ingestion does not improve gastrointestinal barrier function in burn patients","volume":"31","author":"Olguin","year":"2005","journal-title":"Burns"},{"key":"10.1016\/j.clnu.2021.05.033_bib53","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1136\/gut.44.1.96","article-title":"Different intestinal permeability patterns in relatives and spouses of patients with Crohn\u2019s disease: an inherited defect in mucosal defence?","volume":"44","author":"Soderholm","year":"1999","journal-title":"Gut"},{"key":"10.1016\/j.clnu.2021.05.033_bib54","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1053\/j.gastro.2019.05.008","article-title":"Bifidobacteriumbreve Bif195 protects against small-intestinal damage caused by acetylsalicylic acid in healthy volunteers","volume":"157","author":"Mortensen","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clnu.2021.05.033_bib55","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/nature25979","article-title":"Extensive impact of non-antibiotic drugs on human gut bacteria","volume":"555","author":"Maier","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.clnu.2021.05.033_bib56","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/s41467-019-14177-z","article-title":"Impact of commonly used drugs on the composition and metabolic function of the gut microbiota","volume":"11","author":"Vich Vila","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.clnu.2021.05.033_bib57","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1093\/ecco-jcc\/jjv136","article-title":"Dietary intake of inulin-type fructans in active and inactive Crohn\u2019s disease and healthy controls: a case-control study","volume":"9","author":"Anderson","year":"2015","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.clnu.2021.05.033_bib58","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1002\/ibd.21286","article-title":"Probiotic and prebiotic use in patients with inflammatory bowel disease: a case-control study","volume":"16","author":"Hedin","year":"2010","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.clnu.2021.05.033_bib59","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1136\/gut.2011.238568","article-title":"Family studies in Crohn\u2019s disease: new horizons in understanding disease pathogenesis, risk and prevention","volume":"61","author":"Hedin","year":"2012","journal-title":"Gut"}],"container-title":["Clinical Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0261561421002843?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0261561421002843?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T01:03:19Z","timestamp":1759366999000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0261561421002843"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":59,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["S0261561421002843"],"URL":"https:\/\/doi.org\/10.1016\/j.clnu.2021.05.033","relation":{},"ISSN":["0261-5614"],"issn-type":[{"value":"0261-5614","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prebiotic fructans have greater impact on luminal microbiology and CD3+ T cells in healthy siblings than patients with Crohn's disease: A pilot study investigating the potential for primary prevention of inflammatory bowel disease","name":"articletitle","label":"Article Title"},{"value":"Clinical Nutrition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clnu.2021.05.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.","name":"copyright","label":"Copyright"}]}}